In a 55‑year‑old man with acute heart‑failure‑related pulmonary edema whose blood pressure is now normal, will an overnight intravenous furosemide infusion of 200 mg control his symptoms without causing hypotension?

Intravenous Furosemide Infusion for Acute Heart Failure with Controlled Blood Pressure

Yes, an overnight 200 mg furosemide infusion in 100 mL normal saline will effectively control pulmonary edema symptoms in your patient with now-normal blood pressure, and hypotension is unlikely if administered at the recommended rate of ≤4 mg/min. 1

Dosing and Administration Strategy

Your proposed dose of 200 mg furosemide is appropriate for acute pulmonary edema, particularly if the patient was already on chronic diuretic therapy. The FDA label specifies:

• Initial dose for acute pulmonary edema: 40 mg IV push (over 1-2 minutes), with escalation to 80 mg if inadequate response within 1 hour 1
• For high-dose continuous infusion: Add furosemide to normal saline (pH adjusted >5.5) and infuse at ≤4 mg/min 1
• For patients on chronic diuretics: Initial IV dose should be at least equivalent to their oral dose 2

Your 200 mg in 100 mL over ~8-12 hours translates to approximately 0.3-0.4 mg/min, which is well below the 4 mg/min safety threshold, making hypotension highly unlikely from the infusion rate alone.

Hypotension Risk Assessment

Hypotension is not a significant concern in your scenario for several reasons:

1. Blood pressure is now controlled/normal - Guidelines specifically state vasodilators (which can cause hypotension) should only be considered when SBP >90 mmHg 2. Loop diuretics have minimal direct vasodilatory effects compared to nitroglycerin or nitroprusside 3

2. Diuretic-induced hypotension occurs from volume depletion, not acute hemodynamic effects - Recent research demonstrates furosemide produces no immediate extrarenal hemodynamic changes; perfusion changes occur only after diuresis begins (after 20-25 minutes) 4

3. Gradual infusion is safer than bolus - The FDA label warns about excessive diuresis causing circulatory collapse, but this occurs with aggressive bolus dosing or prolonged therapy without monitoring 1

Expected Symptom Control

The infusion will effectively control pulmonary edema symptoms through sustained diuresis:

• Continuous infusion produces superior decongestion compared to intermittent boluses, with significantly greater weight loss (0.63 kg more) and higher 24-hour urine output 5, 6, 7
• Symptom improvement occurs secondary to diuresis, not from direct pulmonary effects - studies show no reduction in pulmonary fluid before diuresis begins 4
• Freedom from congestion is significantly better with continuous infusion (RR: 1.42) 7

Critical Monitoring Parameters

Monitor these parameters overnight to prevent complications:

1. Urine output hourly - Should see prompt diuresis within 20 minutes; expect 134 mL by 20 minutes 4
2. Blood pressure every 2-4 hours - Watch for hypotension from excessive volume loss, not the drug itself
3. Electrolytes (K+, Na+, Cl-) in the morning - Hypokalemia is the primary concern with overnight infusion 1
4. Serum creatinine - Check baseline and next morning to detect acute kidney injury 1
5. Clinical signs of dehydration - Dry mouth, thirst, weakness, oliguria 1

Common Pitfalls to Avoid

Do not:

• Mix furosemide with acidic solutions (pH <7) - it will precipitate 1
• Administer faster than 4 mg/min - increases ototoxicity risk 1
• Withhold potassium supplementation - hypokalemia is common and dangerous, especially if patient is on digoxin 1
• Continue at same rate if oliguria develops - may indicate excessive volume depletion 1

Do:

• Ensure IV line patency - infiltration of alkaline solution causes tissue damage
• Adjust pH of solution to >5.5 before adding furosemide 1
• Have oral furosemide ready for morning transition once stable 2

Guideline-Based Approach

Both ACC/AHA 2022 3 and ESC 2016 2 guidelines recommend:

• Either continuous infusion or intermittent boluses are acceptable (Class I, Level B)
• Dose and duration should be adjusted to symptoms and clinical status 2
• Regular monitoring of symptoms, urine output, renal function, and electrolytes is mandatory 2

The DOSE trial found no significant difference in symptom relief between continuous and bolus administration, but continuous infusion may reduce need for dose escalation 3.